A Healthcare Improvement Intervention Combining Nucleic Acid Microarray Testing with Direct Physician Response for Management of Staphylococcus aureus Bacteremia

Clinical Infectious Diseases

Volumn 66, Issue 1, 2018, Pages 64-71

  Eby, Joshua C ^a   Richey, Morgan M ^b   Platts Mills, James A ^a   Mathers, Amy J ^a,b   Novicoff, Wendy M ^b   Cox, Heather L ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

antimicrobial stewardship; infectious diseases consultation; quality improvement; rapid diagnostic; Staphylococcus aureus bacteremia

Indexed keywords

CEFAZOLIN; CEFTAROLINE; DAPTOMYCIN; LINEZOLID; NAFCILLIN; NUCLEIC ACID; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC THERAPY; ANTIMICROBIAL STEWARDSHIP; ARTICLE; BLOOD CULTURE; CLINICAL ASSESSMENT; CLINICAL OUTCOME; CONFIDENCE INTERVAL; CONSULTATION; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HEALTH CARE QUALITY; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MICROARRAY ANALYSIS; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; PHYSICIAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCUS AUREUS; TOTAL QUALITY MANAGEMENT; AGED; BACTEREMIA; DISEASE MANAGEMENT; DRUG EFFECT; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MOLECULAR DIAGNOSIS; PATIENT REFERRAL; PROCEDURES; STAPHYLOCOCCUS INFECTION; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIOLOGICAL TECHNIQUES; DISEASE MANAGEMENT; FEMALE; HUMANS; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85040630010     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cix727     Document Type: Article

References (40)

1. Robinson JO, Pozzi-Langhi S, Phillips M, et al. Formal infectious diseases consultation is associated with decreased mortality in Staphylococcus aureus bacteraemia. Eur J Clin Microbiol Infect Dis 2012; 31:2421-8.
2. Tissot F, Calandra T, Prod'hom G, et al. Mandatory infectious diseases consultation for MRSA bacteremia is associated with reduced mortality. J Infect 2014; 69:226-34.
3. Isobe M, Uejima E, Seki M, et al. Methicillin-resistant Staphylococcus aureus bacteremia at a university hospital in Japan. J Infect Chemother 2012; 18:841-7.
4. Marchaim D, Kaye KS, Fowler VG, et al. Case-control study to identify factors associated with mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia. Clin Microbiol Infect 2010; 16:747-52.
5. Lodise TP, McKinnon PS, Swiderski L, Rybak MJ. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 2003; 36:1418-23.
6. Gaieski DF, Mikkelsen ME, Band RA, et al. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med 2010; 38:1045-53.
7. Schramm GE, Johnson JA, Doherty JA, Micek ST, Kollef MH. Methicillinresistant Staphylococcus aureus sterile-site infection: The importance of appropriate initial antimicrobial treatment. Crit Care Med 2006; 34:2069-74.
8. van Hal SJ, Jensen SO, Vaska VL, Espedido BA, Paterson DL, Gosbell IB. Predictors of mortality in Staphylococcus aureus bacteremia. Clin Microbiol Rev 2012; 25:362-86.
9. Kothari A, Morgan M, Haake DA. Emerging technologies for rapid identification of bloodstream pathogens. Clin Infect Dis 2014; 59:272-8.
10. Buchan BW, Ginocchio CC, Manii R, et al. Multiplex identification of gram-positive bacteria and resistance determinants directly from positive blood culture broths: Evaluation of an automated microarray-based nucleic acid test. PLoS Med 2013; 10:e1001478.
11. Wojewoda CM, Sercia L, Navas M, et al. Evaluation of the Verigene gram-positive blood culture nucleic acid test for rapid detection of bacteria and resistance determinants. J Clin Microbiol 2013; 51:2072-6.
12. Samuel LP, Tibbetts RJ, Agotesku A, Fey M, Hensley R, Meier FA. Evaluation of a microarray-based assay for rapid identification of gram-positive organisms and resistance markers in positive blood cultures. J Clin Microbiol 2013; 51:1188-92.
13. Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 2016; 62:e51-77.
14. Box MJ, Sullivan EL, Ortwine KN, et al. Outcomes of rapid identification for gram-positive bacteremia in combination with antibiotic stewardship at a community-based hospital system. Pharmacotherapy 2015; 35:269-76.
15. Beal SG, Thomas C, Dhiman N, et al. Antibiotic utilization improvement with the Nanosphere Verigene Gram-Positive Blood Culture assay. Proc (Bayl Univ Med Cent) 2015; 28:139-43.
16. Aitken SL, Hemmige VS, Koo HL, Vuong NN, Lasco TM, Garey KW. Real-world performance of a microarray-based rapid diagnostic for gram-positive bloodstream infections and potential utility for antimicrobial stewardship. Diagn Microbiol Infect Dis 2015; 81:4-8.
17. Beal SG, Ciurca J, Smith G, et al. Evaluation of the Nanosphere Verigene Gram-Positive Blood Culture assay with the VersaTREK blood culture system and assessment of possible impact on selected patients. J Clin Microbiol 2013; 51:3988-92.
18. Neuner EA, Pallotta AM, Lam SW, et al. Experience with rapid microarray-based diagnostic technology and antimicrobial stewardship for patients with gram-positive bacteremia. Infect Control Hosp Epidemiol 2016; 37:1361-6.
19. Wenzler E, Wang F, Goff DA, et al. An automated, pharmacist-driven initiative improves quality of care for Staphylococcus aureus bacteremia. Clin Infect Dis 2017. doi:10.1093/cid/cix315.
20. Liu C, Bayer A, Cosgrove SE, et al; Infectious Diseases Society of America. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011; 52:e18-55.
21. Baddour LM, Epstein AE, Erickson CC, et al; American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee; Council on Cardiovascular Disease in Young; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Nursing; Council on Clinical Cardiology; Interdisciplinary Council on Quality of Care; American Heart Association. on cardiovascular implantable electronic device infections and their management: A scientific statement from the American Heart Association. Circulation 2010; 121:458-77.
22. Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49:1-45.
23. Fowler VG Jr, Sanders LL, Sexton DJ, et al. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: Experience with 244 patients. Clin Infect Dis 1998; 27:478-86.
24. Bai AD, Showler A, Burry L, et al. Impact of infectious disease consultation on quality of care, mortality, and length of stay in Staphylococcus aureus bacteremia: Results from a large multicenter cohort study. Clin Infect Dis 2015; 60:1451-61.
25. L ez-Cort LE, Del Toro MD, G vez-Acebal J, et al; REIPI/SAB Group. Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia. Clin Infect Dis 2013; 57:1225-33.
26. Forsblom E, Ruotsalainen E, Ollgren J, J vinen A. Telephone consultation cannot replace bedside infectious disease consultation in the management of Staphylococcus aureus bacteremia. Clin Infect Dis 2013; 56:527-35.
27. Sullivan KV, Turner NN, Roundtree SS, et al. Rapid detection of gram-positive organisms by use of the Verigene Gram-Positive Blood Culture nucleic acid test and the BacT/Alert Pediatric FAN system in a multicenter pediatric evaluation. J Clin Microbiol 2013; 51:3579-84.
28. Nordenskj d M, Nicholson L, Edstr L, et al. A normal male with an inherited deletion of one exon within the DMD gene. Hum Genet 1990; 84:207-9.
29. Scott LJ. Verigene Gram-Positive Blood Culture nucleic acid test. Mol Diagn Ther 2013; 17:117-22.
30. Corey GR. Staphylococcus aureus bloodstream infections: Definitions and treatment. Clin Infect Dis 2009; 48(suppl 4):S254-9.
31. Fowler VG Jr, Olsen MK, Corey GR, et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 2003; 163:2066-72.
32. Baddour LM, Wilson WR, Bayer AS, et al; American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council. Infective endocarditis in adults: Diagnosis, antimicrobial therapy, and management of complications: A scientific statement for healthcare professionals from the American Heart Association. Circulation 2015; 132:1435-86.
33. del Rio A, Cervera C, Moreno A, Moreillon P, Mir JM. Patients at risk of complications of Staphylococcus aureus bloodstream infection. Clin Infect Dis 2009; 48(suppl 4):S246-53.
34. Liu C, Bayer A, Cosgrove SE, et al; Infectious Diseases Society of America. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011; 52:e18-55.
35. Soriano A, Mart ez JA, Mensa J, et al. Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia. Clin Infect Dis 2000; 30:368-73.
36. Forsblom E, Ruotsalainen E, Mken T, Ollgren J, Lyytiknen O, Jvinen A. Predisposing factors, disease progression and outcome in 430 prospectively followed patients of healthcare-A nd community-associated Staphylococcus aureus bacteraemia. J Hosp Infect 2011; 78:102-7.
37. Kaasch AJ, Barlow G, Edgeworth JD, et al; ISAC, INSTINCT, SABG, UKCIRG, and Colleagues. Staphylococcus aureus bloodstream infection: A pooled analysis of five prospective, observational studies. J Infect 2014; 68:242-51.
38. Aitken SL, Hemmige VS, Koo HL, Vuong NN, Lasco TM, Garey KW. Real-world performance of a microarray-based rapid diagnostic for gram-positive bloodstream infections and potential utility for antimicrobial stewardship. Diagn Microbiol Infect Dis 2015; 81:4-8.
39. Sango A, McCarter YS, Johnson D, Ferreira J, Guzman N, Jankowski CA. Stewardship approach for optimizing antimicrobial therapy through use of a rapid microarray assay on blood cultures positive for Enterococcus species. J Clin Microbiol 2013; 51:4008-11.
40. Roshdy DG, Tran A, LeCroy N, et al. Impact of a rapid microarray-based assay for identification of positive blood cultures for treatment optimization for patients with streptococcal and enterococcal bacteremia. J Clin Microbiol 2015; 53:1411-4.